Press release
Androgenetic Alopecia Pipeline Analysis (2023) Covering Clinical Trials, Emerging Therapies, FDA, EMA, and PMDA Approvals, Competitive Landscape | Kerastem, Addpharma, Biosplice, Aclaris, Kintor Pharma, Cassiopea, Applied Biology, AndroScience
"Androgenetic Alopecia Pipeline Insight, 2023" report by DelveInsight provides a comprehensive analysis of the ongoing clinical development activities and growth prospects across the Androgenetic Alopecia Therapeutics Market.
The report provides a detailed description of the Androgenetic Alopecia drugs, including the mechanism of action, type, stage, route of administration, molecule type, clinical studies, inactive pipeline products, and NDA approvals (if any). The report also covers commercial and clinical activities of the pipeline products from the pre-clinical developmental phase to the marketed stage. Additionally, it presents the ongoing developments in the therapeutics segment, including collaborations, licensing, mergers & acquisitions (M&A), funding, designations, and other product-related details.
Get a Detailed Overview of the Androgenetic Alopecia Clinical Trial Activities and Regulatory Developments in the domain @
https://www.delveinsight.com/report-store/androgenetic-alopecia-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Androgenetic Alopecia Pipeline Analysis
The report provides insights into:
• The report provides detailed insights into the key companies that are developing Androgenetic Alopecia therapies.
• The report also evaluates different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Androgenetic Alopecia treatment.
• It analyzes the key companies involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
• It navigates the emerging Androgenetic Alopecia drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
• Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement, and financing details for future advancement in the Androgenetic Alopecia treatment market.
Learn More about the Clinical and Commercial Development Activities in the Androgenetic Alopecia Therapeutics Domain @
https://www.delveinsight.com/report-store/androgenetic-alopecia-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Androgenetic Alopecia Therapeutics Analysis
Topical minoxidil (ROGAINE) and finasteride (PROPECIA) are the two drugs approved by the US Food and Drug Administration (FDA) for androgenetic alopecia, both of which require at least a 4-6 month trial before noticing improvement and must be used indefinitely to maintain a response. Other off-label therapies used for androgenetic alopecia management include spironolactone, dutasteride, prostaglandin analogs, laser treatments, cyproterone acetate, platelet-rich plasma, and more. Besides drug therapies, hair transplantation is also a preferred surgical approach in androgenetic alopecia treatment.
Significant unmet needs associated with current therapeutic options are significant side effects and hair loss relapse in the future. Even though low-intensity laser therapy has shown promising results in the treatment of androgenetic alopecia, the effectiveness of its treatment remains controversial. So, there is a dire need for novel therapies that offer sustained hair re-growth without future relapse.
The pharma players are making endless efforts to develop novel modalities to cater to these unmet needs. Some major late-stage products are likely to hit the market in the near future, which include BREEZULA (Cosmo Pharmaceuticals), KX-826 (Kintor Pharmaceutical), and XEOMIN (Merz Aesthetics). It is expected that the androgenetic alopecia therapeutics market will experience significant changes due to the launch of these therapies.
There are approx. 12+ key companies developing therapies for Androgenetic Alopecia. Currently, Kintor Pharma is leading the therapeutics market with its Androgenetic Alopecia drug candidates in the most advanced stage of clinical development.
Androgenetic Alopecia Companies in the Therapeutics Market Include:
• Kerastem
• Addpharma
• Cutia Therapeutics
• Biosplice Therapeutics
• Aclaris Therapeutics
• Kintor Pharmaceutical
• Dong-A ST Co., Ltd.
• Cassiopea
• Follica
• Applied Biology, Inc.
• AndroScience Corporation
• AnnJi Pharmaceutical
• Carmell Therapeutics
And Many Others
Emerging and Marketed Androgenetic Alopecia Therapies Covered in the Report Include:
• KX-826: Kintor Pharma
• Clascoterone: Cassiopea
• BREEZULA (clascoterone solution): Cosmo Pharmaceuticals
• XEOMIN (incobotulinumtoxin A): Merz Aesthetics
And Many More
Get an in-depth Assessment of the Emerging Therapies and Androgenetic Alopecia Companies Actively Working in the Market @
https://www.delveinsight.com/sample-request/androgenetic-alopecia-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
The Report Covers the Emerging Androgenetic Alopecia Therapies Under Different Phases of Clinical Development Like -
• Late-stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage product (Phase I)
• Pre-clinical and Discovery stage candidates
• Discontinued and inactive candidates
Route of Administration
Androgenetic Alopecia pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as
• Oral
• Parenteral
• Intravenous
• Subcutaneous
• Topical
Molecule Type
Products have been categorized under various Molecule types such as
• Monoclonal Antibody
• Peptides
• Polymer
• Small molecule
• Gene therapy
Request for Sample PDF to Understand More About the Androgenetic Alopecia Treatment Outlook and Future Perspectives @
https://www.delveinsight.com/sample-request/androgenetic-alopecia-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Table of Content
1. Report Introduction
2. Executive Summary
3. Androgenetic Alopecia Current Treatment Patterns
4. Androgenetic Alopecia - DelveInsight's Analytical Perspective
5. Therapeutic Assessment
6. Androgenetic Alopecia Late-Stage Products (Phase-III)
7. Androgenetic Alopecia Mid-Stage Products (Phase-II)
8. Early Stage Products (Phase-I)
9. Pre-clinical Products and Discovery Stage Products
10. Inactive Products
11. Dormant Products
12. Androgenetic Alopecia Discontinued Products
13. Androgenetic Alopecia Product Profiles
14. Androgenetic Alopecia Companies
15. Androgenetic Alopecia Drugs
16. Dormant and Discontinued Products
17. Androgenetic Alopecia Unmet Needs
18. Androgenetic Alopecia Future Perspectives
19. Androgenetic Alopecia Analyst Review
20. Appendix
21. Report Methodology
Get Detailed Insights About the Reports Offerings @
https://www.delveinsight.com/sample-request/androgenetic-alopecia-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
------------------------------------------------------------------------------------------------------------------------------
Discover DelveInsight's Comprehensive Market Research and Consulting Services:
https://www.delveinsight.com/market-research
Elevate your industry insights with our comprehensive medical devices market assessment reports. Visit to gain a strategic edge through expert analysis and in-depth coverage of the latest trends, innovations, and market dynamics, at:
https://www.delveinsight.com/medical-devices
Empowering Cancer Care: DelveInsight's oncology consulting services offer personalized guidance and cutting-edge expertise to navigate the ongoing clinical, commercial, and regulatory developments, visit for more details:
https://www.delveinsight.com/oncology
Other Trending Healthcare Reports by DelveInsight
Metrorrhagia Market
https://www.delveinsight.com/report-store/metrorrhagia-market
Dysfunctional Uterine Bleeding Market
https://www.delveinsight.com/report-store/dysfunctional-uterine-bleeding-market
Status Epilepticus Market
https://www.delveinsight.com/report-store/status-epilepticus-market
Brain Hemorrhage Market
https://www.delveinsight.com/report-store/brain-hemorrhage-market
Congenital Adrenal Hyperplasia Market
https://www.delveinsight.com/report-store/congenital-adrenal-hyperplasia-market
Ductal Carcinoma in Situ Market
https://www.delveinsight.com/report-store/ductal-carcinoma-in-situ-market
Electroencephelographs (EEG) Pipeline Insight
https://www.delveinsight.com/report-store/electroencephelographs-eeg-pipeline-insight-and-competitive-landscape
Spinal Decompression/Traction Devices Market
https://www.delveinsight.com/report-store/spinal-decompression-traction-devices-market
Bronchopulmonary Dysplasia Market
https://www.delveinsight.com/report-store/bronchopulmonary-dysplasia-market
Drug Hypersensitivity Market
https://www.delveinsight.com/report-store/drug-hypersensitivity-market
Familial Chylomicronemia Syndrome (FCS) Market
https://www.delveinsight.com/report-store/familial-chylomicronemia-syndrome-market
Implantable Infusion Pumps Market
https://www.delveinsight.com/report-store/implantable-infusion-pumps-market
Postmyocardial Infarction Syndrome Market
https://www.delveinsight.com/report-store/postmyocardial-infarction-syndrome-market
Surgery and Radiation Therapy in Brain Cancer Market
https://www.delveinsight.com/report-store/surgery-and-radiation-therapy-in-brain-cancer-market
Acute ischemic stroke (AIS) Market
https://www.delveinsight.com/report-store/acute-ischemic-stroke-ais-market
Acute On Chronic Liver Failure (ACLF) Market
https://www.delveinsight.com/report-store/acute-on-chronic-liver-failure-aclf-market
Biliary Tract Cancers (BTCs) Market
https://www.delveinsight.com/report-store/biliary-tract-cancers-btcs-market
Gene Therapy for Ocular Rare Disease Market
https://www.delveinsight.com/report-store/gene-therapy-for-ocular-rare-disease-market
Hemophagocytic Lymphohistiocytosis Market
https://www.delveinsight.com/report-store/hemophagocytic-lymphohistiocytosis-market
Staphylococcus Aureus Infection Market
https://www.delveinsight.com/report-store/staphylococcus-aureus-infection-market
Treatment-Resistant Hypertension Market
https://www.delveinsight.com/report-store/treatment-resistant-hypertension-market
Urticaria Or Hives Market
https://www.delveinsight.com/report-store/urticaria-or-hives-market
Acute Heart failure Market
https://www.delveinsight.com/report-store/acute-heart-failure-ahf-market
Bowen's Disease Market
https://www.delveinsight.com/report-store/bowens-disease-market
Contrast-Induced Nephropathy Market
https://www.delveinsight.com/report-store/contrast-induced-nephropathy-market
Delirium Market
https://www.delveinsight.com/report-store/delirium-market
Dry AMD MarketEGFR Inhibitors-Induced Skin Disorders Market
https://www.delveinsight.com/report-store/egfr-inhibitors-induced-skin-disorders-market
Excessive Daytime Sleepiness (EDS) Market
https://www.delveinsight.com/report-store/excessive-daytime-sleepiness-eds-market
Gene and Cell Therapies Targeting CNS Disorders Market
https://www.delveinsight.com/report-store/gene-and-cell-therapies-targeting-cns-disorders-market
Glioma Market
https://www.delveinsight.com/report-store/glioma-market
Graves Ophthalmopathy Market
https://www.delveinsight.com/report-store/graves-ophthalmopathy-market
H3N2 Infection Market
https://www.delveinsight.com/report-store/h3n2-infection-market
Nontuberculous Mycobacterial (NTM) Infections Market
https://www.delveinsight.com/report-store/nontuberculous-mycobacterial-ntm-infections-market
Pars Plantis Market
https://www.delveinsight.com/report-store/pars-plantis-market
Pneumothorax Treatment Devices Market
https://www.delveinsight.com/report-store/pneumothorax-treatment-devices-market
Portal Hypertension Market
https://www.delveinsight.com/report-store/portal-hypertension-market
Decompensated Cirrhosis Market
https://www.delveinsight.com/report-store/decompensated-cirrhosis-market
Follicular Lymphoma Market
https://www.delveinsight.com/report-store/follicular-lymphoma-market-insights
Osteochondromas Market
https://www.delveinsight.com/report-store/osteochondromas-market
Hidradenitis Suppurativa Market
https://www.delveinsight.com/report-store/hidradenitis-suppurativa-market
IgG4-Related Disease Market
https://www.delveinsight.com/report-store/igg4-related-disease-market
Lichen Planus Market
https://www.delveinsight.com/report-store/lichen-planus-market
Retinal Vein Occlusion Market
https://www.delveinsight.com/report-store/retinal-vein-occlusion-market
Meniere's Disease Market
https://www.delveinsight.com/report-store/menieres-disease-md-market
Cytokine Release Syndrome Market
https://www.delveinsight.com/report-store/cytokine-release-syndrome-market
Angelman Syndrome Market
https://www.delveinsight.com/report-store/angelman-syndrome-market-forecast
Eosinophilic Gastroenteritis (EGE) Market
https://www.delveinsight.com/report-store/eosinophilic-gastroenteritis-ege-market
Hereditary Transthyretin Amyloidosis (hATTR) Market
https://www.delveinsight.com/report-store/hereditary-transthyretin-amyloidosis-competitive-landscape-and-market
Implantable Infusion Pumps Market
https://www.delveinsight.com/report-store/implantable-infusion-pumps-market
Post-Operative Cataract Surgery Inflammation Market
https://www.delveinsight.com/report-store/post-operative-cataract-surgery-inflammation-market
Antibody-mediated Rejection Market
https://www.delveinsight.com/report-store/antibody-mediated-rejection-market
Contact Info:
Shruti Thakur
Manager - Marketing & International Branding
Email: info@delveinsight.com
428, D21 Corporate Park, Sector-21, Dwarka, New Delhi-110077, India
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Androgenetic Alopecia Pipeline Analysis (2023) Covering Clinical Trials, Emerging Therapies, FDA, EMA, and PMDA Approvals, Competitive Landscape | Kerastem, Addpharma, Biosplice, Aclaris, Kintor Pharma, Cassiopea, Applied Biology, AndroScience here
News-ID: 3275699 • Views: …
More Releases from DelveInsight Business Research LLP
Myelofibrosis Pipeline Report 2025 by DelveInsight: Key Insights into Clinical S …
DelveInsight's "Myelofibrosis Pipeline Insight" report provides comprehensive insights about 35+ companies and 40+ pipeline drugs in the Myelofibrosis pipeline landscape. It covers the Myelofibrosis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Myelofibrosis therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Stay ahead with the latest insights! Download DelveInsight's comprehensive Myelofibrosis…
Hemophilia Pipeline Landscape Report 2025: DelveInsight's Exclusive Report on Cu …
DelveInsight's "Hemophilia Pipeline Insight" report provides comprehensive insights about 80+ companies and 80+ pipeline drugs in the Hemophilia pipeline landscape. It covers the Hemophilia pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Hemophilia therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Stay ahead with the latest insights! Download DelveInsight's comprehensive Hemophilia…
DelveInsight's NMIBC Pipeline 2025: Unveiling Drug Development Progress, Clinica …
DelveInsight's, "Non Muscle Invasive Bladder Cancer Pipeline Insight" report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Non Muscle Invasive Bladder Cancer pipeline landscape. It covers the Non Muscle Invasive Bladder Cancer pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Non Muscle Invasive Bladder Cancer therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive…
Hearing Loss Pipeline 2025 by DelveInsight: Exploring Novel Mechanisms of Action …
DelveInsight's "Hearing Loss Pipeline Insight" report provides comprehensive insights about 32+ companies and 35+ pipeline drugs in Hthe earing Loss pipeline landscape. It covers the Hearing Loss pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Hearing Loss therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Stay ahead with the latest insights!…
More Releases for Androgenetic
Rising Hair Loss Cases Drive Growth In The Androgenetic Alopecia Treatment Marke …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Androgenetic Alopecia Treatment Market Size Growth Forecast: What to Expect by 2025?
The market for treating androgenetic alopecia has seen significant growth in recent times. It's projected to increase from a value of $2.29 billion in 2024 to about $2.44 billion in 2025, following a compound annual growth rate…
Androgenetic Alopecia Market Insights and Future Outlook
Introduction
Androgenetic alopecia (AGA), also known as male-pattern or female-pattern baldness, is the most common form of hair loss, affecting millions of individuals globally. It is primarily driven by genetic and hormonal factors and often leads to psychological distress, reduced confidence, and demand for effective treatment options.
The global market for androgenetic alopecia has expanded rapidly in recent years, driven by a combination of medical innovations, increasing acceptance of aesthetic procedures, and…
Rising Hair Loss Cases Drive Growth In The Androgenetic Alopecia Treatment Marke …
The Androgenetic Alopecia Treatment Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Current Androgenetic Alopecia Treatment Market Size and Its Estimated Growth Rate?
The androgenetic alopecia treatment market has shown strong growth, projected to grow from $2.29 billion in 2024 to $2.47 billion…
Androgenetic Alopecia Market Size Forecast Between 2023-2032
Androgenetic alopecia, commonly known as male or female pattern baldness, is a prevalent form of hair loss affecting millions worldwide. With its impact extending beyond mere aesthetics to psychological well-being, the androgenetic alopecia market stands as a critical segment within the dermatological landscape. This article delves into the nuances of this market, exploring its competitive dynamics, growth prospects, and pivotal factors influencing its trajectory.
Download Free Androgenetic Alopecia Market Sample Report…
Androgenetic Alopecia Market Siz a Growing CAGR of 9.60% by 2028
"Research analysts leverage their years of experience and expertise to construct an accurate and error-free Androgenetic Alopecia Market document. The vision and dynamism of an expert team expedite work and contribute to creating the best research report. This marketing report acts as a robust connection between the business and crucial market information that would otherwise go to waste. Core values such as trust, integrity, and authenticity are central to…
Androgenetic Alopecia Market to Reach US$ 10,717.6 Million by 2033
Market Overview:
According to the IMARC Group, the androgenetic alopecia market exhibited a market size of US$ 10,717.6 Million in the year 2023 and is projected at a CAGR of 5.6% during 2023-2033. This can be attributed to the extensive investments made by various leading market players in developing efficient treatment modalities that can provide satisfying and long-term results.
The report offers a comprehensive analysis of the androgenetic alopecia market in the…
